Oncology & Cancer

Targeting MAPK4 emerges as a promising therapy for prostate cancer

The battle against late-stage prostate cancer might have found a potential new strategy to combat this deadly disease. Research led by Baylor College of Medicine reveals in the Journal of Clinical Investigation that the enzyme ...

Medical research

Unanticipated response to estrogen at the single cell level

A team led by researchers at Baylor College of Medicine found that not only do individual mammalian cells in a population fail to respond synchronously to estrogen stimulation, neither do individual gene copies, known as ...

Diseases, Conditions, Syndromes

Cleaning up tuberculosis and salmonella infections

The cellular recycling system in zebrafish is capable of eating harmful bacteria and thus resist infections such as tuberculosis and salmonellosis. That is written by Leiden biologists from the group of Annemarie Meijer. ...

Medications

New targets for ischemic drugs

Russian scientists investigated the role of opioid receptors in protecting the heart from coronary disease: the lack of its blood supply. These receptors are mainly responsible for pain regulation. It turned out that they ...

Oncology & Cancer

A new way to cut the power of tumors

Instead of tackling tumors head-on, an international team of researchers from the University of Geneva (UNIGE) and the Amsterdam UMC, location VUmc in Amsterdam has chosen to regulate their vascularization by intervening ...

Diseases, Conditions, Syndromes

RNA processing and antiviral immunity

The RIG-I like receptors (RLRs) are intracellular enzyme sentries that detect viral infection and initiate a first line of antiviral defense. The cellular molecules that activate RLRs in vivo are not clear.

page 1 from 7